Has been shown not to inhibit nitric oxide synthesis, both in vitro and in vivo. This salt form is more stable than the dihydrochloride.
Product Details
| Alternative Name: | SDMA . 2HABS, H-Arg(di-Me)-OH . 2HABS (symmetrical) |
| |
| Formula: | C8H18N4O2 . 2C12H10N2O4S |
| |
| MW: | 202.2 . 556.6 |
| |
| CAS: | 30344-00-4 (free base) |
| |
| Purity: | ≥97% (TLC) |
| |
| Appearance: | Orange powder. |
| |
| Solubility: | Soluble in methanol (20mg/ml). |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Handling: | Protect from light. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure: P. Vallance, et al.; Lancet
339, 572 (1992), and references cited therein.,
Abstract;
L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells: J.B. Hibbs Jr., et al.; J. Immunol.
138, 550 (1987),
Abstract;
Related Products
